Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
BeiGene Initiates New Phase 3 Trial of Anti-PD-1 Antibody Tislelizumab Combined with Chemotherapy as First-line Treatment for Patients with Advanced Squamous Non-Small Cell Lung Cancer in China 2018-08-09 17:05
I-Mab's Announces China Clinical Trial Approval of Long-acting hGLP-1 to Treat Type 2 Diabetes 2018-08-09 16:16
TOT BIOPHARM raises US$102 million in Series B Financing Round 2018-08-08 19:00
VolitionRx Announces $9 Million Private Placement 2018-08-08 18:00
I-Mab Biopharma and MorphoSys Announce China IND Submission of TJ202/MOR202 2018-08-08 09:01
Ward MM and Adapt Analytics announce a partnership to integrate AI and machine learning into Ward MM's clinical decision support engine 2018-08-07 21:00
Adlai Nortye Announces Engagement of Lars E. Birgerson, M.D., Ph.D., as CDO and President/CEO of Adlai Nortye USA 2018-08-07 01:15
CPHI to Hold Second Quarter 2018 Earnings Conference Call on Wednesday August 15, 2018 at 8:30 a.m. ET 2018-08-06 20:45
China Biologic Reports Financial Results for the Second Quarter of 2018 2018-08-04 04:30
IMPACT Therapeutics Raises $30 Million In Series C Financing 2018-08-03 16:48
Ascletis' NDA for Its All-oral HCV Treatment Accepted by CFDA 2018-08-01 18:52
GC Pharma Reports Q2 2018 Results 2018-08-01 12:24
Man Who Cloned His Dying Service Dog in Seoul Returns to Bare "His Soul" 2018-07-31 19:05
WuXi Biologics Commenced Process Validation in MFG2 2018-07-31 07:55
ABL Bio and I-Mab Biopharma Announce Global Collaboration on Innovative Bispecific Antibodies 2018-07-30 21:00
CStone's MEK Inhibitor CS3006 Receives IND Approval in China 2018-07-30 12:51
China Biologic Products to Report Second Quarter 2018 Financial Results 2018-07-27 20:00
Effective governance holds key to ensuring people's health 2018-07-27 09:50
Foresee Pharmaceuticals Announces Results from a Phase 1 Clinical Study, Highlighting Promising Safety, Tolerability and Pharmacokinetic Profile of FP-045, a Potent ALDH2 Activator 2018-07-26 19:30
WuXi STA's Jinshan Site Passes Fourth U.S. FDA Inspection 2018-07-26 08:00
1 234 235 236 237 238 430